Navigation Links
PharmAthene To Host First Quarter 2013 Conference Call And Webcast On Wednesday, May 8, 2013

ANNAPOLIS, Md., May 6, 2013 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that its financial and operating results for the first quarter of 2013 will be released on Wednesday, May 8, 2013.

PharmAthene management will host a conference call to discuss the Company's first quarter 2013 financial and operational results. The call is scheduled to begin at 4:30 pm Eastern Time on Wednesday, May 8, 2013 and is expected to last approximately 30 minutes.  The dial-in number within the United States is 866-515-2915.  The dial-in number for international callers is 617-399-5129.  The participant passcode is 78016828.

A replay of the conference call will be available beginning at approximately 6:30 pm Eastern Time on May 8, 2013 until approximately 11:59 p.m. Eastern Time on June 7, 2013.  The dial-in number to access the replay from within the United States is 888-286-8010.  For international callers, the dial-in number is 617-801-6888.  The participant passcode is 70157811.

The conference call will also be webcast and can be accessed from the Company's website at  A link to the webcast may be found under the Investor Relations section of the website. 

SOURCE PharmAthene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. PharmAthene Reports Year-End 2012 Financial And Operational Results
2. PharmAthene To Host Year-End 2012 Conference Call And Webcast On Wednesday, March 13, 2013
3. PharmAthene To Present At The Noble Financial 9th Annual Equity Conference On Tuesday, January 22, 2013
4. PharmAthene Reports Third Quarter 2012 Financial Results
5. PharmAthene Reports First Quarter 2012 Financial Results
6. PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress
7. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
8. PharmAthene to Present at the 24th Annual ROTH Conference on Monday, March 12, 2012
9. PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012
10. Anthera Announces First Quarter 2013 Financial Report and Conference Call
11. Regeneron Reports First Quarter 2013 Financial and Operating Results
Post Your Comments:
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/25/2015)... Francisco, CA (PRWEB) , ... November 25, 2015 ... ... microbial genomics company uBiome, were featured on AngelList early in their initial angel ... launching an AngelList syndicate for individuals looking to make early stage investments in ...
(Date:11/24/2015)... ... 24, 2015 , ... The United States Golf Association (USGA) today announced Dr. ... Award. Presented annually since 1961, the USGA Green Section Award recognizes an individual’s distinguished ... , Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology in ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, December ... Helen Torley , president and CEO, will provide a corporate overview. ... New York at 1:00 p.m. ET/10:00 a.m. PT . ... investor relations, will provide a corporate overview. --> th ...
Breaking Biology Technology:
(Date:11/9/2015)... , Nov. 09, 2015 ... the addition of the "Global Law ... their offering. --> ) ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) has ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... RESTON, Va. , Oct. 29, 2015 ... announced today that it has released a new version ... Daon customers in North America ... gains. IdentityX v4.0 also includes a FIDO UAF ... customers are already preparing to activate FIDO features. These ...
Breaking Biology News(10 mins):